8,232,262, "Salts of Isophosphoramide Mustard and Analogs Thereof as Anti-Tumor Agents," related to pharmaceutical compositions, methods of treatment and methods of making a DNA cross-linker, which includes palifosfamide (ZIO-201

8,080,578, titled "Methods for Treatment with Bucindolol Based on Genetic Targeting

Advaxis Inc., of Princeton, N.J., was granted a patent, titled "Compositions and Methods for Treatment of Cervical Cancer," which protects the use of its HPV constructs in late-stage cervical cancer

7,939,090, titled "System and method for the treatment of cancer, including cancers of the central nervous system," which covers the combination of a dendritic cell-based vaccine combined either before or concurrently with chemotherapy at the recurrence of disease

7,901,682 for methods of treatment in cancer, pathological angiogenesis and inflammation using an antibody or antibody fragment that binds sphingosine-1-phosphate

Silence Therapeutics plc, of London, received a notice of allowance for a patent directed to methods of treatment using the oncology target PKN-3, a protein kinase C-related molecule believed to play a role in the growth of cancer cells and metastasis formation

It covers the composition of matter, pharmaceutical composition and method of treatment for SG410

7,488,736, titled "Thienopyridinone Compounds and Methods of Treatment

It covers both composition of matter claims using single-stranded DNA expression vector technologies and methods of treatment using the company's therapeutic compound

7,169,390, titled "Compositions and Methods for the Treatment and Prevention of Cancer, Angiogenesis, and Inflammation

7,083,813 B2, titled "Methods for The Treatment of Peripheral Neural and Vascular Ailments

NexMed Inc., of East Windsor, N.J., received a notice of allowance for a patent titled "Prostaglandin Compositions & Methods of Treatment for Male Erectile Dysfunction

7,052,832, titled "Methods for the Treatment of Cellular Proliferative Disorders," which describes the methods of identifying cells' susceptibility to reovirus infection

7,012,070, covering methods of treatment for a broad range of indications with its lead compound, 2-methoxyestradiol (2ME2), which is in Phase II cancer trials

ReNeuron Group plc, of Guildford, UK, received a notice of allowance for a patent covering methods of treatment of different types of brain damage by the transplantation of conditionally immortal stem cells

6,890,911, titled "Method for the treatment of inflammation," relating to its core mycobacterial cell wall technology

6,852,760, covering compositions and methods of treatment for diabetes and other glucose metabolism disorders

6,753,325 B2 titled "Topical Compositions and Methods for Treatment of Adverse Effects of Ionizing Radiation," which relates to its topical treatment for radiation dermatitis called QR-335

6,763,264 titled "Method of Treatment Using Electroporation Mediated Delivery of Drugs and Genes